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Nitrosamines comprise a large group of potentially toxic compounds occurring in the
environment as by-products of various manufacturing, agricultural and natural processes.
Nitrosamines are produced from reaction of nitrite with a suitable secondary amine in an
acidic matrix; these acidic conditions can occur in environmental media and in the
mammalian gastrointestinal (GI) tract. This research focused on the stability, transfer, and
impacts of the environmentally relevant nitrosamines, N-nitrosodimethylamine (NDMA),
N-nitrosmorpholine (NMOR), and N-nitrosoatrazine (NNAT) (formed from reaction of
nitrite with dimethylamine, morpholine, and atrazine), using the chicken egg and embryo
model systems. Chicken eggs were used to determine nitrosamine transfer between a
hydrophilic medium (egg white or albumin) and a lipophilic medium (yolk) via a
biomembrane (vitelline membrane). Results from these studies with unfertilized chicken
eggs showed that the selected nitrosamines transferred from the egg white to yolk where
they were relatively stable. NNAT has a relatively higher affinity for the lipophilic yolk
fraction, which suggests that it may have a greater potential to bioconcentrate than
NDMA and NMOR. An understanding of the transfer behavior of nitrosamines can be
used to assess bioavailability and fate, as well as potential environmental and biological

impacts. An observed decrease in total nitrosamine in the yolk with time may indicate
denitrosation, releasing nitrous acid, which can decompose to nitrite and nitric oxide
(NO), an important biological messenger during embryonic and fetal development. Thus
teratogenicity of these compounds was assessed using chicken embryos. Major defects
observed after exposure to these selected compounds included ectopic heart,
gastroschisis, caudal regression, craniofacial hypoplasia, and neural tube defects. A
significant relationship was observed between malformed embryos and NNAT (0.46 µg).
Additionally nitrotyrosine concentrations (a marker of NO-mediated stress) in NNAT
treated, malformed embryos were greater than those observed in treated, normalappearing embryos. Results indicate that NNAT may be teratogenic and that
nitrotyrosine, a marker of NO-dependent oxidative stress, maybe reflective of one
biochemical pathway through which nitrosamines exert teratogenic effects.
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INTRODUCTION
Nitrosamines comprise a large class of mutagenic, teratogenic and carcinogenic
chemicals found in the environment as by-products of various manufacturing, agricultural
and natural processes (Magee and Barnes 1967, Lijinksy and Epstein 1970, Loeppky et
al. 1994, McKnight et al.1999). Nitrosamines generally affect the GI tract, associated
organs, and the brain (Mirvish 1995). Exposure to nitrosamines is estimated to be
approximately 1.10 µmol/day (Tricker 1997, Lijinksy 1999). Nitrosamines are found in
certain foods that contain nitrite or are exposed to nitrogen oxides (Walker 1990).
Humans are also exposed to a wide range of nitrogen-containing compounds and
nitrosating agents which can react in vivo under the acidic conditions of the gastric
environment to form nitrosamines (Mirvish 1975, 1977, Lijinsky and Taylor 1977). Nnitroso compounds (NOCs) formed endogenously in the maternal stomach may be
transmitted via the placenta to the fetus (Cowdin et al. 2003). Studies demonstrate that
exposure to NOCs may be associated with birth defects such as neural tube defects and
cleft palate, neonatal deaths and stillborns in rodents but the mechanisms are not yet
understood (WHO, Takeuchi 1984, Carozza et al. 1995).
Partitioning between liquid and solid phases, membrane penetration, entry in the
organs of the host, and subsequent biochemical effects determine chemical toxicity. The
transfer behavior of nitrosamines can be studied using model systems such as the chicken
egg. Aside from its use as a model of embryological development, chicken eggs can be
used to study the partitioning of nitrosamines between hydrophilic or lipophilic biological
compartments or phases.
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The fertilized chicken egg and the developing embryo are useful models for the
study of teratogenicity. The chick embryo provides an acceptable measure of
embryotoxic potency (Jelinek et al. 1985) and chicken embryos are widely used to study
development and developmental abnormalities (Rosenquist et al. 2001, 2007, 2010, Lie et
al. 2010).
Denitrosation of nitrosamines in the endoplasmic reticulum may be a pathway of
detoxification (Lee 1996, Williams 2004) that can lead to increases in nitric oxide which
can cause cell injury. Hiramoto (2002) demonstrated that nitrosamines decomposed on
contact with reactive oxygen species, accompanied by release of NO. Nitrotyrosine is a
product of tyrosine nitration mediated by reactive nitrogen species such as peroxynitrite
anion and nitrogen dioxide. Its concentration is a marker of NO-dependent oxidative
stress and may reflect one pathway by which nitrosamines exert their teratogenic effects.
The three nitrosamines explored in this thesis are N-nitrosodimethylamine
(NDMA), N-nitrosomorpholine (NMOR) and N-nitrosoatrazine (NNAT), representing
environmentally significant nitrosamines. NDMA is a known hepatotoxin and carcinogen
(Lijinsky et al. 1972, IARC). NMOR has also been found to be carcinogenic in many
animal species (Preussmann and Tricker 1991, WHO). NNAT can be formed from
atrazine, a widely used triazine herbicide that has been detected in groundwater (Spalding
2003).
The unfertilized chicken egg and developing embryo were used to determine:
(1) stability and transfer of the selected nitrosamines among biological compartments,
(2) teratogenic potential, and (3) impacts on nitrotyrosine concentrations.
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LITERATURE REVIEW
Nitrosamine Formation
N-Nitroso compounds (NOC) consist of nitrosamines [RN(NO)R`] and
nitrosamides [RN(NO)COR`]. N-Nitrosamines comprise cyclic nitrosamines (e.g.,
NMOR) and dialkylnitrosamines (e.g., NDMA) (Magee and Barnes 1967, Mirvish 1977).
Nitrosamines first drew attention after an outbreak of acute hepatotoxicity in Norwegian
sheep, which was linked to the presence of NDMA in nitrite-preserved fish meal (Magee
and Barnes 1967). Magee and Barnes (1967) were the first to discover that NDMA was
acutely hepatotoxic in a number of animal species. In murine models, nitrosamines have
been found to induce tumors of the esophagus, nose, liver, kidneys, pancreas and other
organs (Mirvish 1977).
Nitrosamines have been found in foods that contain nitrite or are exposed to
nitrogen oxides. These foods include fish, alcoholic beverages and cured meats (Walker
1990), especially bacon in which concentrations of 10-100 µmol/kg have been found
(Lijinksy 1999). Cooking method, temperature and time influences the formation of
nitrosamines in meat products (Lee et al. 2003). Humans are also exposed to a range of
nitrogen-containing compounds and nitrosating agents which can react in vivo to form
nitrosamines. Nitrosamines may originate from the reaction of nitrite and nitrosatable
molecules under the acidic conditions of the gastric environment (Mirvish 1975, 1977,
Lijinsky and Taylor 1977).
Mean nitrite levels were 0.1-2.6 and 26-54 µM for fasting gastric juice of pH < 5
and > 5, respectively (Xu and Reed 1993). An anion transport mechanism actively

4
secretes 25% of the absorbed nitrate into the saliva. Oral bacteria reduce 5% of the
ingested nitrate to nitrite (Spiegelhalder et al. 1976, McKnight et al. 1999). While nitrite
itself can be sufficiently toxic, it also serves as a nitrosating agent (Spiegelhalder et al.
1976, Tenovuo.1986). The reduction of ingested or endogenous nitrate accounts for
almost 80% of gastric nitrite in the normal acidic stomach. The remaining 20% of gastric
nitrite arises from ingested nitrite found in processed foods (Mirvish 1977, 1983).
Nitrosatable molecules include secondary amines, tertiary amines, alkylureas and
amino acids (Mirvish 1970, Lijinsky et al. 1972). Under the acidic conditions of the
human stomach, nitrite is protonated to nitrous acid (HNO2). HNO2 can then
spontaneously form dinitrogen trioxide (N2O3), nitric oxide (NO), and nitrogen dioxide
(NO2). NO+ can also be donated by N2O3 to secondary and tertiary amines that can then
form potentially carcinogenic nitrosamines in vivo (Leaf et al.1989). Under neutral
conditions, NO can be formed from bacterial reduction of nitrite. NO in turn can react
with molecular oxygen to form the nitrosating agents N2O3 and N2O4. Inducible nitric
oxide synthase (iNOS) activity of inflammatory cells is also a source of NO. All of these
mechanisms of endogenous nitrosation account for almost 40-75% of the total human
exposure to nitrosatable compounds.
Secondary amines can be nitrosated to produce a nitrosamine. The formation of
nitrosamines from secondary amines can be described by the following reactions (Eq. 13):

Na+

O N O

Sodium nitrite

H+ Cl-

H O N O
Nitrous acid

Na+ Cl-

(1)
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H
H O N O

H+

H O N O

N O

H

H
N O
R
Secondary amine Nitrosonium ion

R N+ N O
R

N

O

(2)

Nitrosonium ion

Protonated nitrous acid

Nitrous acid

R N

H2O

H2O

R N N O

H3O+

(3)

R
Secondary N-nitrosoamine

The kinetics of the nitrosation reaction depends on the pH of the medium and the
pKa of the amine. Formation of a nitrosating agent is regulated by pH. The nitrite ion is
protonated to form HNO2 (pKa 3.37) (Eq. 1). This reaction is favored under acidic
conditions (which occur in the human stomach). Under these conditions, HNO2 may
protonate, lose water, and be converted to N2O3 or form other activating nitrosating
species, including the nitrosonium ion, nitrosyl thiocyanate, or nitrosyl halide (Eq. 2).
Secondary amines will react with the nitrosonium ion to form nitrosamines (Eq. 3). The
mechanism for nitrosation involves nucleophilic attack on the nitrosonium ion to form the
nitrosamine. The unprotonated form of the amine is the more reactive form, so reactivity
is greater for weak bases (Mirvish 1975, Mergens 1982). Thus, nitrosation occurs readily
with weakly basic secondary amines such as morpholine and relatively slowly with
strongly basic secondary amines such as dimethylamine (DMA). The rate of the reaction
depends on the concentrations of the non-ionized amine and HNO2. At pH > 1, the
principal nitrosating agent is N2O3. The rate of the reaction is proportional to the
concentration of nitrous anhydride and the square of nitrous acid, thus the rate of the
reaction increases tenfold for each one unit decrease in pH (Mirvish 1970, 1972).

6
Under suitable conditions, primary amines may be alkylated to form secondary
amines which can then be nitrosated. Likewise, tertiary amines can be dealkylated to
form secondary amines which can be nitrosated to form nitrosamines. Tertiary amines
with dimethylamine functional groups have been identified as potent NDMA precursors
(Shafer et al. 2010).
Nitrosamines can also be formed in an alkaline solution when the nitrosating agent
is present as N2O3 or N2O4 gas (Challis et al. 1978). The mechanism by which this occurs
is still not understood completely; however a study (Challis et al. 1978) shows that only
the unprotonated amino-nitrogen of the selected compounds participates in the nitrosation
reactions. The possible reaction which may be occurring can be described as follows (Eq.
4):
H2O

HNO3 + HNO2

R2NH

ON-NO3

ON-NO3

2+

R2NNO + HNO3

(4)

R2NH
Unsymmetrical tautomer
of N2O4

Transition

Secondary

state

Nitrosamine

Nitrosamine formation also can occur in the lipid phase, when the reactive amines
are soluble (Mergens 1982). Unsaturated fatty acids have been shown to enhance (nearly
double in fatty acid ester solutions) nitrosation of dicyclohexylamine in a lipid medium,
under aprotic conditions, upon exposure to low concentrations of NO2 (Pryor 1981). The
nitrosating species under these conditions is HONO formed by the NO2-unsaturated ester
reactions. Pryor (1981) reported that the rate of nitrosation of the amine nearly doubles in
the fatty acid solutions. This suggests that the HNO2 (nitrous acid) formed from the
reaction between NO2 and the unsaturated fatty acid may be participating in nitrosation of

7
the amine. Only the unprotonated (more reactive) amine species would be soluble in a
lipophilic medium. The pH dependence of the reaction is therefore eliminated and the
probability of a reaction occurring between an amine and a nitrosating agent is very high
(Pryor 1981, Mergens 1982).
Aside from pH, the rate of nitrosation is influenced by the presence of thiocyanate
ions, halide ions, and formaldehyde, which accelerate the reaction, and ascorbic acid and
α-tocopherol that block the formation of N-nitroso compounds (Mirvish 1977). Ascorbic
acid and α-tocopherol compete for the available nitrite (i.e. N2O3 and H2NO2+) and are
thus capable of inhibiting the formation of nitrosamines. Ascorbic acid reacts rapidly
with nitrite under acidic conditions to reduce HNO2 to NO and is itself oxidized to
dehydroascorbic acid. α-Tocopherol reduces NO2 to NO in organic solvents and lipids,
and its emulsions in water reduce nitrite to NO (Mirvish 1986).

Selected Nitrosamines
The nitrosamines explored in this study are N-nitrosodimethylamine (NDMA), Nnitrosomorpholine (NMOR), and N-nitrosoatrazine (NNAT). The physicochemical
properties of these nitrosamines and their parent compounds are reported in Tables I and
II, respectively:
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Table I. Physicochemical properties of selected nitrosamines
Structure and Name

Properties

N-Nitrosodimethylamine

(NDMA)

Volatile yellow oily liquid;
Soluble in water, organic solvents and
lipids;
Photosensitive;
Molecular weight = 74.1;
Water solubility = 290 mg/mL;
Density = 1.005 g/cm³;
Log Kow = -0.57;
Log Koc = 1.07

Yellow crystals;
N-Nitrosomorpholine
(NMOR)

Soluble in organic solvents;
Photosensitive;
Molecular weight= 116.1;
Water solubility = >100 mg/mL;
Density = 1.11 g/cm³;
Log Kow = -0.43
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Table I continued
Structure and Name

Properties
Photosensitive;
N-Nitrosoatrazine
(NNAT)

Molecular weight= 244.1;
Water solubility= 0.29 mg/mL;
Density= 1.42 g/cm3
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Table II. Physicochemical properties of parent compounds
Structure and Name
Dimethylamine

pKa

Properties

10.7

Colorless compressed liquefied

(DMA)

gas with pungent odor ;
Molecular weight= 450.1;
Water solubility= 3540 mg/mL;
Density= 0.67 g/cm3;
Log Kow = -0.38

Morpholine

8.7

Colorless oily volatile liquid;
Water solubility- miscible;
Molecular weight= 87.1;
Density- 1.01 g/cm3;
Log Kow = -0.86

Atrazine

1.7

White solid;
Molecular weight= 215.7;
Water solubility= 0.033
mg/mL; Density= 1.187 g/cm3;
Log Kow = 2.34
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NDMA
NDMA is a known hepatotoxin (Lijinsky and Greenblatt 1972, Pegg 1980, Archer
et al. 1994) and is classified as an IARC (International Agency for Research on Cancer)
group 2A carcinogen (probably carcinogenic to humans) (IARC 1987, Lijinsky et al.
1972). NDMA may be present in air due to reactions between dimethylamine (DMA) and
nitrogen oxides.
NDMA is widely used as an industrial solvent (Mirvish 1977). It can be
synthesized by soil bacteria from various precursor substances, including nitrate, nitrite,
and amine compounds. NDMA is also an inadvertent by-product of industrial processes,
such as reaction of alkylamines DMA with nitrogen oxides, nitrous acid, or nitrite salts,
or transnitrosation via nitro or nitroso compounds. NDMA may thus be present in
discharges of rubber manufacturing, leather tanning, pesticide manufacturing, food
processing, meat tinning and dye manufacturing industries (Mitch et al. 2003, Blicharz et
al. 2005, Vocht et al. 2007). NDMA has also been identified in baby pacifiers, emissions
from diesel vehicle exhaust and it can be released from industrial sources as a
contaminant of products such as liquid rocket fuel (Sen et al. 1985, Mitch et al. 2003).
NDMA has been detected in the air in chemical (0.05-0.5 µg/m3) and rubber industries
(0.07-0.14 µg/m3) (Fajen et al. 1979).
Dietary sources of NDMA include beer, fish and fish products, dairy products,
infant formula, cured meats, cereals and vegetables. In fact, NDMA accounts for almost
86% of the total nitrosamines in salted fish in China (Bulushi et al. 2009). The
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contribution of NDMA from food is considered high even though concentrations in most
food products are relatively low (Fristachi and Rice 2007, Shafer et al. 2010).
California’s Department of Public Health (CDPH) has set 10 ng/L notification
levels (advisory levels for chemicals in drinking water that lack maximum contaminant
levels) for NDMA in drinking water. Most nitrosamine releases from industries are to
sewage and subsequently water. NDMA concentrations as high as 0.11 mg/L have been
detected in effluents from manufacturing industries (Mitch et al. 2003). DMA and nitrite
may enter surface water streams from agricultural runoff. NDMA may also be formed
during treatment of drinking water. Water treatment plants incorporating a chlorination
process (e.g., sodium hypochlorite) produce NDMA from precursors (WHO, Fristachi
and Rice 2007, Asami et al. 2009). High levels of NDMA have been detected in outdoor
and indoor pools and hot tubs (Walse and Mitch 2008). Free chlorine (HOCl) may react
with ammonia to form monochloramine (NH2Cl) which in turn may react with DMA to
form dimethylhydrazine ((CH3)2NNH2) which then oxidizes to NDMA (Eq 5-7) (Mitch et
al. 2003).
NH3 + HOCl → NH2Cl (MC) + H2O

(5)

NH2Cl + (CH3)2NH → (CH3)2NNH2 + H+ + Cl-

(6)

(CH3)2NNH2 + 2NH2Cl + H2O → (CH3)2NNO + 2NH3 + 2H+ + 2Cl-

(7)

13
NMOR
NMOR (nitrosated morpholine) is carcinogenic in many animal species (WHO,
Tricker and Preussmann 1991) and it has been found to be mutagenic (Manson et al.
1978). NMOR is an IARC group 2B carcinogen (sufficient evidence of carcinogenesis in
several experimental animal species) (WHO) as it is responsible for inducing liver, nasalcavity, tracheal, oesophagus and stomach tumors in several animal models (Lofberg
1985).
Approximately 25000 metric tonnes of morpholine are produced industrially each
year (WHO). It is a versatile chemical that is used as an intermediate for rubber
polymerization accelerators, corrosion inhibitors, synthesis of optical brighteners, crop
protection agents, dyes and drugs, polishes/waxes and food additives (WHO, Mirvish
1972, Sen et al 1987, Grosjean 1991, Vocht et al. 2007). Some countries still use
morpholine in toiletry and cosmetic products, and in several direct and indirect food
additive applications. Human exposure to morpholine arises from gaseous and aqueous
emissions and directly from some of its uses. NMOR was produced in mice exposed to
morpholine and NO2 (Mirvish et al. 1981). NO2 itself is a pollutant formed from
combustion processes such as gas cooking, cigarette smoking, automobile exhaust, and
flame drying of foods (Cooney and Ross 1987). Morpholine emissions mainly result from
its manufacture and use in the chemical industry. Morpholine has been detected in a
wide variety of foods and tobacco with the source being the coatings of wax on fruit or
on packaging papers (WHO, Sen 1986). 90-4830 µg/kg of morpholine was detected in
the waxed cardboard containers used to package snuff and snuff tobacco itself was found
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to contain NMOR (10-690 µg/kg) (Brunnemann et al. 1982). NMOR levels of up to 140670 µg/kg have been detected in waxes used to protect apples (Tricker et al. 1989).
Like NDMA, NMOR has been identified as an air pollutant in chemical (0.07
µg/m3-5.1 µg/m3) and aircraft tire industries (0.6 µg/m3- 27 µg/m3) (Fajen et al. 1979,
Spiegelhalder and Preussmann 1983). NMOR has been detected in the rubber industry
and in diesel engine crankcase emissions (Lofberg 1985). Disinfected wastewater
effluents have also been shown to contain NMOR (Kulshrestha et al. 2010). NMOR has
been identified in drinking water at maximum concentrations of about 3 ng/L (Padhye
2010).

NNAT
NNAT (nitrosated atrazine) can be formed from atrazine, a widely used broadleaf
triazine herbicide that has been detected in groundwater (Spalding et al. 2003). Exposure
to atrazine may occur on the application of the herbicide or consumption of contaminated
food or water (Mirvish et al. 1991). Due to the widespread application of agrichemicals in
the Midwest, some groundwaters are contaminated with nitrate and atrazine.
Groundwater contaminated with atrazine often contains nitrate. A 1997 study (Gosselin et
al. 1997) reported detection of atrazine in 70 Nebraska domestic wells. Wells
contaminated by atrazine had a median nitrate-nitrogen concentration of 11.5 µg/L. High
concentrations of atrazine (1500 µg/kg) have been detected in Wisconsin, where the wells
also have high nitrate levels (Meisner et al. 1993). Elevated concentrations of nitrate and
atrazine create the potential for NNAT formation after ingestion. Thus exposure to
atrazine and nitrate may occur via consumption of contaminated water. Atrazine is a
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secondary amine that can be readily nitrosated to form nitrosoatrazine under suitable
conditions (Mirvish et al. 1991). Atrazine nitrosates almost 200 times faster than DMA at
pH 2 (Wolfe et al. 1976) and NNAT is relatively stable at alkaline pH (Mirvish et al.
1991). NNAT is more photolabile than NMOR in water or CH2Cl2 which may be due to
UV absorption by its triazine ring (Wolfe et al. 1976, Mirvish et al. 1991). NNAT is also
mildly mutagenic in the Ames assay (Weisenburger et al. 1988, Gammon et al. 2005).
Meisner (1993) found that exposure of lymphocytes to NNAT resulted in chromosome
breakage.
Nitrosamine Sources and Exposure
Nitrosamines have been studied extensively in foods as they are found in certain
foods that contain nitrite or are exposed to nitrogen oxides. These foods include dried
salted fish, alcoholic beverages and cured meats (Mirvish 1977, Walker 1990), especially
bacon in which concentrations of 10-100 µg/kg have been found (Lijinksy 1999). Human
exposure to nitrosamines is estimated to be approximately 1.10 µmol/d. Major sources of
exposure are the diet (0.79 µmol/d, 80-120 µg/d; 72% of the total exposure), occupational
exposure (0.15-0.30 µmol/d; 25%), cigarette smoking (0.02 µmol/d, 3.4 µg /d; 2%), and
miscellaneous sources, including pharmaceutical products (Brambilla et al. 1985,
Dawson and Lawrence 1987), cosmetics, indoor and outdoor air (0.001 µmol/d, 0.1 µg/d;
1%) (Tricker 1997). Consumer products such as foods, beverages, pharmaceutical drugs
and cosmetics that contain nitrosatable compounds and nitrite or have been exposed to
nitrous oxides can be a source of nitrosamines (Rosenberg et al. 1980, Tenovuo 1986,
Lijinksky 1999, Yurchenko and Molder 2006).

16
While nitrate levels are highest in vegetable products (189 mg of nitrate/serving),
nitrite levels are highest in meat and bean products (1.84 mg/serving). Alcohol, meat and
dairy products contain the highest concentrations of nitrosamines (0.531 µg/serving)
(Griesenbeck et al. 2009) (serving indicates standard serving sizes in the United States as
reported by the Centers for Disease Control).
While there is considerable research on nitrosamine exposure from food, concern
has been expressed about nitrosamine formation, occurrence and exposure in the
environment. A number of drugs are secondary or tertiary amines (e.g. chlorpheneramine,
cefadroxil, diphenhydramine, ethambutol, furosemide, metoprolol, procainamide,
propranolol, and ranitidine) and can be easily nitrosated to form NOC. Large doses of
drugs are ingested by mouth and their chronic presence in the GI tract could be hazardous
if they nitrosate to form carcinogenic NOCs. For example, oxytetracycline reacts
endogenously with nitrite to form NDMA. Similarly, methapyrilene and
chlorpheniramine can also react with nitrite to form NDMA (Mirvish 1995).
Occupational exposure to volatile nitrosamines occurs in rubber/latex and leather
curing industries. NDMA and NMOR have been detected in the air of rubber industries.
These are thought to arise from the reaction of exhaust NO2 with amines arising from
vulcanization accelerators (Mirvish 1995). Average daily intake of NDMA by individuals
working in rubber industries is 0.8 µg/m3 (Tricker et al. 1989). The estimated daily intake
of NMOR by individuals working in rubber industries is 3.8 µg (Tricker 1989).
Of the three nitrosamines considered for this study, the presence of and exposure
from NDMA has been examined most extensively. NDMA concentrations as high as 70
µg/L have been detected in German beer, although levels are usually much lower (5-10
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µg/L). In the U.S., the estimated dietary exposure to NDMA from beer is almost 0.3-0.97
μg/d (Walker 1990). NDMA has also been detected in bacon (17 µg/kg), smoked pickled
fish (32 µg/kg) and Japanese broiled squid (300 µg/kg) (Lijinksky 1999). NDMA has
been identified in Korean dried seafood products and cooking has been shown to increase
the NDMA content (from about 147 to 630.5 µg/kg) (Lee et al. 2003). NDMA
concentrations of 0.003-0.4 mg/L have been found in groundwater near rocket engine
testing facilities (Mitch et al. 2003). High concentrations of nitrosamines have been
detected in latex gloves and studies have shown that these can migrate and be potentially
toxic (Feng et al. 2009). NDMA is still found in some fish products (Mirvish 2008). A
daily tolerance limit of 4 - 9.3 ng NDMA/kg/d or 280– 650 ng/d for a 70 kg person has
been identified (Schafer et al. 2010).

Nitrosamine Carcinogenicity and Mutagenicity
In animal models, nitrosamines induce tumors of the liver, nose, kidneys, pancreas,
esophagus and other organs. Several studies have shown that tumors are induced in mice
after treatment with sodium nitrite together with various secondary amines (Mirvish
1972). More than 300 NOCs are carcinogenic in one or more animal species (Preussmann
and Stewart 1984, Hasegawa et al. 1998). Exposure to nitrosamines has been associated
with mortality from cancers of the oesophagus, oral cavity, and pharynx (Straif et al.
2000). NNAT was also mutagenic in the Ames assay (Weisenburger et al. 1988,
Gammon et al. 2005).
Nitrosamines require metabolic activation to exert carcinogenic and mutagenic
effects. Cytochrome P450 (P450) enzymes activate nitrosamines in the endoplasmic
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reticulum to form α-hydroxynitrosamines, which spontaneously decompose to form
monoalkylnitrosamines and alkyldiazohydroxides (Magee and Barnes 1967, Mirvish
1977, 1995). Formation of monoalkylnitrosamines followed by alkyldiazohydroxides is
known as dealkylation. Alkyldiazohydroxides are capable of alkylating nucleophiles to
form diazoalkanes, some of which can alkylate DNA bases especially at N-7 and O-6 of
guanine and O-4 of thymine (Mirvish 1995). This induces mutations which are thought to
initiate carcinogenesis. DNA damage due to alkylation of N-7 in guanine also generates
reactive oxygen species such as superoxide (O2-) and hydrogen peroxide (H2O2).
Consequences include increased lipid peroxidation, protein adduct formation, and proinflammatory cytokine activation (Tong et al. 2010).

Teratogenic Potential of Nitrates, Nitrites and Nitrosamines
Maternal exposure to nitrosatable compounds may be related to birth defects
(WHO, Takeuchi 1984, Carozza et al. 1995, Croen et al. 2001, Cowdin et al. 2003,
Brender et al. 2004, Manassaram et al. 2007). Associations have been found between
occupational exposure in agricultural work and pesticides and the risk of anencephaly (a
neural tube defect that occurs when the cephalic end of the neural tube fails to close,
resulting in the absence of a major portion of the brain, skull, and scalp) and other
adverse pregnancy outcomes such as spontaneous abortion and preterm delivery
(Greenlee et al. 2004, Lacasana et al. 2006).
NDMA decreased the hatching of fertilized eggs in carp (Bieniarz et al. 1996). Ten
mg/kg of methylnitrosourea induced limb and other defects in murine models (Koyama et
al. 1970, Iannaccone et al. 1982). Exposure to N-methyl-N-nitrosourea also increased
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gross malformations in mice (Bossert and Iannaccone, 1985) and N-methyl-N’-nitro-Nnitrosoguanidine induced mid line defects in mice (Inouye and Murakami 1978). NDMA
is lethal to or inhibits the growth of chick embryos (Maduagwu and Bassir 1979). A
methyl derivative of NDMA, N-Methyl-N-(α-acetoxy)methyl-nitrosamine is a strong
teratogen in a mouse limb bud culture system (Stahlmann et al. 1983). Takeuchi (1984)
showed that exposure to N-nitroso compounds was associated with neural tube defects
and cleft palate in mice. Certain nitrosatable drugs have been associated with an
increased risk of craniosynostosis (premature fusion of the sutures of the skull). It has
been suggested that ischaemia (restriction in blood supply) and reperfusion injury (tissue
damage caused after a period of ischemia) leading to an increase in the rate of formation
of NO may be the cause of dysmorphogenesis (Gardner et al. 1998).
A 2004 epidemiological study reported an association between intake of dietary
nitrite and neural tube defects in humans (Brender et al. 2004). Croen showed that
maternal exposure to nitrate-contaminated drinking water was associated with risk of
neural tube defects (Croen et al. 2001). Exposure to nitrate in drinking water at levels
greater than 45 mg/L (the maximum contaminant level) and in groundwater at
concentrations below the maximum contaminant level has been associated with an
increased risk for anencephaly (Croen 2001). Many other studies have indicated links
between drinking water containing nitrate and neural tube defects (NTDs) (Ward et al.
2005). The risk of NTDs from high levels of nitrates in food/water increases if mothers
are exposed to nitrosatable drugs (Brender et al. 2004, Manassaram 2007).
Elevated concentrations of dietary nitrosamines have been significantly
associated with gastroschisis (failure of the abdominal wall to close) (Torfs et al. 1998).
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In fact, several studies have shown an increase in the rates of gastroschisis and other
abdominal wall defects in the past two decades (Laughon et al. 2003, Alvarez et al. 2007,
Collins et al. 2007, Vu et al. 2008). Annola et al. (2009) demonstrated that the human
fetus can be exposed to NDMA from maternal blood circulation.

Nitrosamine Dealkylation and Denitrosation
Research is limited regarding the denitrosation of nitrosamines and fate in
environmental media and in the mammalian digestive tract. Nitrosamines can be reduced
across the N-N bond or the N-O bond. Reduction across the N-N bond releases the parent
amine and nitrous acid. The nitrous acid released can decompose to nitrogen dioxide,
nitric oxide and water. It may also decompose to nitric acid, nitrous oxide and water (Eq.
8). Near the site of NO production, NO reacts with dissolved oxygen to form N2O3 and
N2O4 which react with water at neutral pH to form nitrite and nitrate, and with amines to
form nitrosamines (Mirvish 1995). Reduction across the N-O bond yields a hydrazine
which can be further reduced to the parent amine and ammonia (Eq. 9). Hydrazine
formation may be a pathway for bioactivation as it is a highly reactive base and reducing
agent.
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Metabolism of nitrosamines includes dealkylation and denitrosation. Denitrosation
in the endoplasmic reticulum may be a pathway of detoxification (Lee 1996, Williams
2004). There are two denitrosation mechanisms mediated by P450 isoenzymes. One
electron reduction produces NO and the secondary amine which may be dealkylated. One
electron abstraction liberates NO via an oxidative mechanism involving the formation of
an aminium cation radical. An alkylidenaminoalkane is formed due to the loss of a proton
which in turn hydrolyses to the primary amine and the corresponding aldehyde
(Haussmann and Werringloer 1987, Appel et al. 1991). Studies with rat liver microsomes
have demonstrated that denitrosation of NDMA accounts for the formation of
methylamine and the production of NO via an oxidative mechanism, which is a precursor
of nitrite (Keefer et al. 1987, Haussmann 1987). Although denitrosation is a possible
mechanism of detoxification of the nitrosamine, toxic effects due to NO and its
conversion to nitrite and nitrate (due to intermediate formation of the NO2 radical) are
possible (Appel et al. 1991).
Denitrosation can increase NO and can lead to cell injury (Lee 1996, Williams
2004). The liberated NO also may result in formation of nitrosamines via nitrosation.
Hiramoto (2002) demonstrated that on contact with reactive oxygen species (ROS), Nnitrosamines decomposed, with release of NO. Nitrosamine metabolism may result in the
formation of ROS, including hydrogen peroxide (H2O2), superoxide anion (O2-), and
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hydroxyl radicals (OH•). These ROS may cause oxidative stress and possible induction of
hepatocellular necrosis, carcinogenesis, tumor formation and other cell damage (Farombi
et al. 2009).

Nitric oxide, Peroxynitrite and Nitrotyrosine
Nitric oxide (NO) is an important biological messenger that mediates critical
physiological processes, including gene regulation, immune regulation, apoptosis,
neurotransmission and vascular smooth muscle cell relaxation (Stamler et al. 1992,
Tiboni and Clementini 2004). NO synthesis via oxidation of L-arginine involves unusual
chemistry that has uncovered novel aspects of eukaryotic enzymology. L-arginine
synthesizes NO by the enzyme nitric oxide synthase (NOS) (Stamler et al. 1992, Tiboni
and Clementini 2004). Of the three isoforms of NOS, the constitutive isoforms nNOS
(neuronal NOS) and eNOS (endothelial NOS) produce small amounts of NO while iNOS
(inducible NOS) produces much larger amounts of NO (Dijkstra et al. 1998). The
biological activity of NO is due to its direct actions on the enzyme guanylyl cyclase. The
activation of guanylyl cyclase by low concentrations of NO is the major pathway of NO
signaling that is involved in the regulation of many physiological functions such as
neurotransmission and vascular smooth muscle relaxation (Moncada et al. 1991).
Studies show that a change in NO can alter NO- mediated intracellular signaling
which can adversely affect embryonic and fetal development (Fantel and Person 2002,
Trapp et al. 2006). Excessive or inadequate NO can lead to reproductive and
developmental failure (Tiboni and Clementini 2004). Inhibition of NO may lead to limb
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defects (Tiboni and Clementini 2004). Abnormally high levels of NO are involved in the
hypotension associated with endotoxic shock (Kilbourn and Belloni 1990) and
inflammatory response-induced tissue injury (Mulligan et al. 1991). A recent study by
Alexander et al. (2007) demonstrated that changes in NO levels resulted in morphological
defects of the heart, neural tube and eyes in chick embryos. While NO itself can be
cytotoxic, it may also exert adverse effects via production of other oxidizing agents
(Dijkstra et al. 1998).
Peroxynitrite (ONOO-) is produced by the reaction of NO with superoxide radical
(O2•) which occurs at a high rate (Kaur 1994). Peroxynitrite is a potent oxidizing agent
that has been implicated in various pathological conditions. The adverse effects of
ONOO- include tissue damage by lipid peroxidation and DNA strand breaks leading to
apoptosis and oxidation of protein sulfydryl groups (Dijkstra et al. 1998). The half-life of
ONOO- in vivo is quite short which is why it is usually measured in terms of the
formation of the comparatively more stable nitrotyrosine (Takizawa et al. 1999).
Peroxynitrite can decompose to products that nitrate aromatic amino acids, which can be
markers of NO- dependent oxidative damage in vivo (Kaur 1994). One of these markers is
3-nitrotyrosine. Measuring 3-nitrotyrosine may be a useful way to provide evidence of
NO- mediated pathology as it is indicative of a more intense oxidative stress (Kaur 1994,
Pacher et al. 2007).
Nitrotyrosine is produced when ONOO- reacts with tyrosine (i.e. it induces
nitration of tyrosine) or to proteins containing tyrosine residues (Halliwell et al. 1997,
Gal et al. 1997). Tyrosine nitration involves addition of a –NO2 group near the –OH
group on the tyrosine aromatic ring. For tyrosine nitration to occur, a hydrogen atom is
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abstracted from tyrosine to form a tyrosyl radical. The tyrosyl radical then rapidly reacts
with nitrogen dioxide to form 3-nitrotyrosine (Pacher et al. 2007). This nitration of
tyrosine residues can subsequently result in the loss of protein structure, function and
activity, which may compromise cell signal transduction, alter cytoskeletal organization
and bring about a change in the catalytic activity of enzymes. This is why tyrosine
nitration is considered a vital aspect of peroxynitrite-mediated cytotoxicity (Pacher et al.
2007).
Nitrotyrosine levels are elevated in many pathological conditions where
inflammation is observed. Nitrotyrosine is also elevated in the plasma protein of people
with chronic renal failure, atheroschelrotic plaque, and ischemia-reperfusion injury. High
nitrotyrosine levels are also observed in people with diseases that have a high oxidative
stress burden such as diabetes (Takizawa et al. 1999, Nakazawa et al. 2000, Mohiuddin et
al. 2006). Elevated nitrotyrosine concentrations have been found in malformed murine
embryos (Trapp et al. 2006).

Use of chicken egg and embryo model systems to assess bioavailability and potential
teratogenicity
Health risks do not always correlate with the total amount of toxicant in an
environmental matrix or a biological system. While all of the nitrosamine that is present
may be considered bioaccessible, assessment of potential impacts requires a
determination of bioavailability. Bioavailability is the rate and extent to which an active
agent is absorbed and becomes available at the site of action. The bioaccessible fraction

25
is considered to represent the maximum amount of contaminant that is available for
intestinal absorption. Bioaccessible fractions of nitrosamines may be absorbed and
transferred into the blood (or lymph) stream (Oomen et al. 2002) and bioavailability
depends, in part, on the route of exposure (Caussy 2003, Harmsen 2007).
Partitioning between liquid and solid phases, membrane penetration, entry in the
organs of the host, and subsequent biochemical effects determine nitrosamine toxicity.
The partitioning behavior of nitrosamines can be studied using model systems. Aside
from serving as a model of embryological development, chicken eggs can be used to
study the transfer of nitrosamines among biological compartments.
In chicken eggs, the yolk is centered in the albumin or egg white and is surrounded
by the vitelline membrane (Fig.1). The egg white (pH 7.9-8.0) makes up 60% of the total
egg weight and is comprised of the proteins ovomucin, globulins, conalbumin,
ovalbumin, lysozyme, ovotransferrin and ovomucoid (Palmer 1944, Mine 2007). Water is
the major constituent of egg white (88%) while proteins account for 11%. Polar amino
acids alternate along the peptide chain in egg white. Egg yolk contains nonpolar
triacylglycerols and polar phospholipids. In the yolk (pH 5.9-6.0), polyedric droplets are
surrounded by a membrane in which high density lipoprotein granules and low density
lipoprotein micelles are held in the aqueous phase. Egg yolk lipids include cholesterol,
triglycerides, cerebrosides and phospholipids (Palmer 1944, Mine 2007). The vitelline
membrane is composed of glycoprotein, carbohydrate and lipids (Ternes 2001). Thus the
egg serves as an ideal model to study the transfer of the selected nitrosamines between
the hydrophilic and lipophilic phases.
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Fig.1. Structure and components of the chicken egg.
The embryotoxic potential of a compound depends on factors such as dose, critical
window of exposure and sensitivity of the developing morphogenetic system at the time
of administration. Also important is the metabolic activity of the morphogenetic system
that transforms a substance to active or inactive metabolites.
The chicken egg and developing embryo are useful models for the study of
teratogenicity. Chicken embryos are widely used to study development and
developmental abnormalities (Rosenquist et al. 2001, 2007, 2010, Lie et al. 2010). The
chick embryo in ovo represents a morphogenetic system that includes epigenetic tissue
interactions and it possesses a drug metabolizing capacity. The chick embryo provides an
acceptable measure of embryotoxic potency (Jelinek et al. 1985). It is an inexpensive and
rapid in vitro model system. Hamburger and Hamilton staged the chicken embryo in
1951, describing the various features of the chicken that can be observed at specific times
(mean of a range) after fertilization. The chicken embryo reaches the blastoderm stage
by the time the egg is laid. Three h after fertilization the newly formed single cell divides
and division continues until there are many cells grouped in a small, whitish spot visible
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on the upper surface of the egg yolk. Within the first 24 h, the alimentary tract appears
and the brain crease, nervous system and head fold begin to form. The heart starts to beat
within 48 h (Hamburger and Hamilton 1951). The external form of chicken embryos at
various stages of development can be studied beginning with the second or third day of
incubation by carefully breaking open or windowing an egg each day (Matthew et al.
2007). Defects such as neural tube abnormalities can also be detected by observing the
developing embryo within 36 h of incubation (Madeleine et al. 2005). Thus the chick
embryo model can provide a useful tool to screen for toxicity and developmental
abnormalities.
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MATERIALS AND METHODS
Chemical Reagents and Eggs
All chemicals used in the experiments were analytical grade. Atrazine (98%) was
obtained from Chem Service (West Chester, PA). NDMA and NMOR were purchased
from Sigma-Aldrich (St. Louis, MO). NNAT was synthesized using the method of
Mirvish et al. (1991). Fertilized chicken eggs were obtained from Charles River
Laboratories International, Inc (Wilmington, MA).

Nitrosamine Stability and Transfer among Biological Compartments
Unfertilized chicken eggs were used to characterize the stability and transfer of the
selected nitrosamines. To determine the stability of NDMA, NMOR and NNAT, the egg
white, membrane and yolk were separated and weighed. One mL of deionized, distilled
(DD) water containing 1 mg nitrosamine/mL was added to individual fractions of the egg.
After incubation on a rotary shaker at room temperature (ca. 25 °C) for different time
intervals (4, 6, 10, 16 and 24 h), the yolk, egg white and membrane fractions were
separated and weighed. Using methodology similar to the EPA SW846 method for
nitroaromatics and nitramines, nitrosamines were extracted from each egg fraction. In
this procedure, acetonitrile was added to each fraction and the samples were placed on
the shaker for 16 h. The supernatant was centrifuged, filtered and analyzed by HPLC
(Shimadzu, Kyoto, Japan), using a 250 × 4.6 mm Keystone NA column (Thermo
Hypersil-Keystone, Bellefonte, PA).
To characterize the transfer of the selected nitrosamines between the biological
compartments, NDMA, NMOR and NNAT were added to the air cell, via a window, and
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the treated eggs were placed on a rotary shaker at room temperature for varying time
intervals (1, 4, 6, 10, 16, 24, 48, 72 and 120 h). After incubation and subsequent
separation of the fractions, the same method of extraction, detection and quantification
was used to determine the amount of nitrosamine in each fraction of the egg.
To determine nitrosamine transfer within the egg, its distribution between just two
fractions was studied. To determine the distribution between the egg white and
membrane, the yolk was removed and the nitrosamine was added to the egg whitemembrane matrix. For the distribution between membrane and yolk, the egg white was
removed after which the nitrosamine was added. To determine the distribution between
egg white and yolk, the nitrosamine was added to the egg. Treated eggs were placed on a
rotary shaker at room temperature for varying time intervals (1, 4, 10 and 24 h), after
which the amount in each fraction was determined. Extraction and analysis of the
nitrosamine were carried out using the method described above. All values were
corrected for recovery.

Teratogenic Potential
Experiments were performed using a chick embryo model to determine doseresponse and evaluate the teratogenic potential of atrazine, NDMA, NMOR and NNAT.
Pathogen-free fertilized chicken eggs were incubated in a forced air incubator at 38 °C
and 65–75% relative humidity for 30 h (HH stage 9 – 10; Hamburger and Hamilton
1951). The eggs were treated in the air cell at HH stage 9 -10, when there are 7 to 10
somites (Hamburger and Hamilton 1951), by delivering 50 µL of DD water containing
various concentrations of each of the selected nitrosamines using a micropipette.
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Negative controls included fertilized eggs injected with DD water. The eggs were
returned to the incubator after dosing. The embryos were harvested at days 3 (72 h, HH
stage 20) and 5 (120 h, HH stage 27) and examined microscopically for soft tissue and
skeletal abnormalities, including: neural tube defects (failure of the neural tube to close),
craniofacial hypoplasia (tissue deficiency or agenesis, failure of an organ to develop
during embryo development), microphthalmia (abnormally small eye/s), anophthalmia
(absence of one or both eyes), ectopic heart (displacement of the heart outside the
thoracic cavity), gastroschisis (intestines and other organs develop outside the fetal
abdomenfailure of the abdominal wall to close), and caudal regression (lack of or the
degenerative regression of the caudal aspect of the embryo leading to absence or lack of
caudal stuctures).
Embryos were compared to the negative controls to identify developmental
anomalies and assess mortality and abnormality rates. The amounts of nitrosamine in the
50 µL injections and concentrations of the three nitrosamines used to treat fertilized
chicken eggs are reported in Table III.
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Table III. Dose and concentration of selected nitrosamines
Compound

Dose

Concentration

(µg in 50 µL DD

(µg/g egg matrix (excluding egg shell))

water)

NDMA

NMOR

NNAT

12.5

0.2

25.0

0.5

50.0

0.9

25.0

0.5

250.0

4.7

1250.0

23.6

2500.0

47.2

5000.0

94.3

7500.0

141.5

0.06

0.001

0.01

0.002

0.2

0.004

0.5

0.009

0.9

0.017
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Table III continued
Compound

Dose

Concentration

(µg in 50 µL DD

(µg/g egg matrix (excluding egg shell))

water)

NNAT

Atrazine

1.8

0.03

3.6

0.07

5.5

0.10

7.3

0.14

14.5

0.27

16.5

0.31

Nitrotyrosine Determination
Measuring the stable 3-nitrotyrosine may be a useful way to provide evidence of
NO-mediated pathology as it is indicative of intense oxidative stress. Nitrotyrosine was
measured in tissue sonicates of embryos treated with DD water (negative controls),
embryos treated with NNAT that appeared normal and embryos treated with NNAT that
were malformed using the OxisResearch™ Bioxytech® Nitrotyrosine Enzyme
Immunoassay (EIA) for Nitrotyrosine (Portland, OR). The EIA is a “sandwich” ELISA.
The antigen that is captured by a solid phase monoclonal antibody is detected with a
biotin labeled goat polyclonal anti-nitrotyrosine. A streptavidin peroxidase conjugate then
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binds to the biotinylated antibody. A tetramethylbenzidine (TMB) substrate is added and
the yellow product is measured at 450 nm. Nitrotyrosine concentrations (expressed in
terms of nmol/µg Protein) were measured in tissue sonicates of five-day-old embryos
treated with different doses of NNAT (0.06, 0.23, 0.46, 0.91 and 3.63 µg/50 µL) and
deionized, distilled water (controls). Protein concentrations (expressed as µg/µL) were
determined in control and treated embryos using the Bradford assay (Bradford 1976,
Kruger 2002).

HPLC Analyses
The nitrosamines (NDMA, NMOR and NNAT) and atrazine were identified and
quantified by HPLC. HPLC analyses were carried out by injecting 10 µL of sample onto
a 250 × 4.6 mm Keystone NA column (Thermo Hypersil-Keystone, Bellefonte, PA).
HPLC mobile phases and operating conditions for the nitrosamine analyses are given in
Table IV.

TABLE IV. HPLC conditions for nitrosamine analyses
Compound

Wavelength

Flow rate

Mobile phase

(nm)

(mL/min)

NDMA

220

1.0

70:30 Methanol:Water

NMOR

248

1.0

50:50 Water:Acetonitrile

NNAT

246

1.0

50:50 Water:Acetonitrile

Atrazine

235

1.0

50:50 Water:Acetonitrile
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Statistical Analyses
Chi square tests (SAS, Cary, NC) were used to examine the relationship between
NDMA, NMOR and NNAT treatment and the subsequent effect observed (i.e.,
embryo death and malformation). Differences in nitrotyrosine concentrations between
and within groups (i.e., treated malformed, treated normal and controls) were
determined by analysis of variance (ANOVA) in SAS (SAS Institute Inc., Cary, NC).
Risks of mortality and malformations from exposure to the three nitrosamines (versus
the non-exposed group i.e. controls) were determined by Relative Risk in SAS (SAS
Institute Inc.). Relative risk is the risk of developing a particular condition (in this
case malformations and mortality) for one group compared to another group:
Relative risk = P exposed / P non-exposed. Analysis of relative risk is used frequently in the
statistical analysis of binary outcomes where the outcome of interest has relatively
low probability. For all analyses, statistical significance was accepted at a p value =
0.05.
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RESULTS AND DISCUSSION
Stability and Transfer of Selected Nitrosamines
To study the stability and transfer of nitrosamines, experiments were carried out using
unfertilized chicken eggs. Results indicate that NDMA, NMOR and NNAT partition into
the yolk where they are fairly stable and it is hypothesized that this may impact NO
concentrations during embryo development in fertilized eggs. Standard deviations (n=3)
were typically small for egg white and yolk measurements but large for membrane
measurements due to the difficulty in separating this fraction.

Stability of NDMA
To determine the stability of NDMA in the various fractions of the egg, a known amount
was added to each fraction and the amount remaining was determined over time.
The amounts of NDMA in the egg white and yolk were relatively constant over time
(Fig. 2), indicating that NDMA is quite stable in the egg white and yolk.
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Fig. 2. NDMA stability in egg white (albumin) (●) and yolk (○) in a 24-h experiment.
Error bars indicate mean standard deviations; where absent bars fall within symbols.

NDMA Transfer among Egg Fractions
NDMA amount and concentration within the egg white decreased during 120 h of
incubation (Fig. 3). The NDMA content increased in the yolk, while it decreased in the
membrane from 1 to 24 h and then increased to 72 h after which a decrease was observed
(Fig. 3). The decrease in NDMA in the egg white and concomitant increase in the yolk
with time suggests that NDMA partitions from the egg white into the yolk.
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Fig. 3. NDMA concentrations (µg/g) in the albumin (egg white), membrane and yolk,
and total amount of NDMA (mg) in the albumin (egg white) (●), membrane (○) and yolk
(▼) during 120 h of incubation. Error bars indicate mean standard deviations; where
absent bars fall within symbols.

The total amount of NDMA in the egg decreased during 120 h of incubation
(Table V). This suggests that NDMA gradually decomposes. The NDMA may be
denitrosating to the parent compound (DMA) and/or is being transformed to other
products (not determined).
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TABLE V. Total NDMA in the egg during a 120-h experiment (1 mg added)

a

Time

NDMA in Egg

(h)

(mg)

1

NDMA Lost or Unaccountable
( (mg)

(%)

0.70 (0.009)a

0.30

30

4

0.73 (0.004)

0.27

27

6

0.68 (0.003)

0.32

32

10

0.67 (0.010)

0.33

33

24

0.66 (0.007)

0.34

34

48

0.65 (0.009)

0.35

35

72

0.65 (0.008)

0.34

34

120

0.60 (0.013)

0.40

40

Values in parenthesis indicate standard deviations (n = 3)

Transfer between Fractions
On analyzing the distribution of NDMA between two layers, NDMA decreased in
the egg white with time while the amount in the vitelline membrane increased (Table VI).
This shows transfer of NDMA from the egg white to the membrane. In the membraneyolk matrix, the amount of NDMA in the membrane decreased with time while that in the
yolk remained constant after an initial increase (Table VII), suggesting transfer from the
membrane to the yolk. The distribution of NDMA between the egg white and yolk also
indicated transfer from the egg white into the yolk over a period of time (Table VIII).
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TABLE VI. NDMA in the membrane and egg white of an egg white-membrane
matrix during a 24-h experiment (1 mg added)
Egg white
Time

Amount

Relative

Membrane
Amount

percent

Amount

Loss

percent

(h)

(mg)

(%)

(mg)

(%)

(mg)

(%)

1

0.33

60

0.22

40

0.55

45

48

0.58

42

67

0.48

52

76

0.46

54

(0.004)a
4

0.30

(0.008)
52

(0.021)
10

0.16

24

0.11
(0.024)

0.28
(0.005)

33

(0.001)

a

Relative

Total

0.32
(0.005)

24

0.35
(0.003)

Values in parenthesis indicate standard deviations (n = 3)
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Table VII. NDMA in the membrane and yolk of a membrane-yolk matrix during a
24-h experiment
Membrane
Time

Amount

Yolk

Relative

Amount

Percent

Total
Relative

Amount

Loss

Percent

(h)

(mg)

(%)

(mg)

(%)

(mg)

(%)

1

0.88

69

0.39 (0.009)

31

1.27

23

60

0.40 (0.023)

40

1.00

0

47

0.49 (0.013)

53

0.93

7

42

0.54 (0.006)

58

0.93

7

43

0.45 (0.010)

57

0.79

21

38

0.40 (0.011)

63

0.64

36

(0.008)a
4

0.60
(0.006)

6

0.44
(0.017)

10

0.39
(0.019)

16

0.34
(0.011)

24

0.24
(0.014)

a

Values in parenthesis indicate standard deviations (n = 3)
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Table VIII. NDMA in the egg white, membrane and yolk during a 24-h experiment
Egg white

Membrane

Time Amount Relative Amount
Percent
(mg)

(%)

(mg)

1

0.42

63

0.16

4

0.33
(0.013)

6

0.43

0.34

43

0.21

66

0.32
(0.104)

a

0.10

14

(0.005)

0.31

0.11

15

0.27

31

0.07
(0.036)

0.26

22

0.07

0.89

0.51
(0.039)a

Values in parenthesis indicate standard deviations (n = 3)

0.68

32

1.05

20

1.00

0

0.52

48

1.37

13

0.90

10

13

65

(0.015)
8

(%)

26

(0.106)
20

(mg)

43

(0.011)

(0.107)
36

0.45
(0.012)

(0.002)

(0.019)
24

23

(0.014)

(0.014)
16

(%)

26

Loss

Percent
(mg)

(0.001)

(0.015)
10

0.27

Total

Relative Amount

(%)

(0.019)
31

Amount

Percent

(h)

(0.009)a

Relative

Yolk

57
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Stability of NMOR
To determine NMOR stability, a known amount of NMOR was added to individual
fractions of the egg. The amount of NMOR in the egg white and yolk were constant for
the duration of the experiment (Fig. 4), suggesting stability in both fractions.

Fig. 4. NMOR in albumin (egg white) (●) and yolk (○) in a 24-h experiment. Error bars
indicate mean standard deviations; where absent bars fall within symbols.

NMOR Transfer among Egg Fractions
The amount and concentration of NMOR in the egg white decreased with time.
Membrane-associated NMOR increased up to 24 h after which it decreased. The amount
and concentration of NMOR within the yolk steadily increased with time up to 120 h
(Fig. 5).
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Fig. 5: NMOR concentrations (µg/g) in the albumin (egg white), membrane and yolk,
and total NMOR (mg) in the albumin (egg white) (●), membrane (○) and yolk (▼)
during 120 h of incubation. Error bars indicate mean standard deviations; where absent
bars fall within symbols.

The total amount of NMOR in the egg remained constant for the first 24 h then
decreased through the remainder of the 120-h experiment (Table IX).

44
TABLE IX. Total NMOR in the egg during a 120-h experiment (1 mg added)
Time

Amount of

NDMA Lost or Unaccountable

NMOR in egg

a

(h)

(mg)

(mg)

(%)

1

0.88 (0.004)a

0.12

12

4

0.81 (0.013)

0.19

19

6

0.84 (0.054)

0.16

16

10

1.18 (0.014)

0.06

5

24

1.15 (0.012)

0.10

8

48

0.78 (0.019)

0.22

22

72

0.79 (0.121)

0.21

21

120

0.79 (0.118)

0.21

21

Values in parenthesis indicate standard deviations (n = 3)

Transfer between Fractions
On analyzing the distribution of NMOR between the egg white and membrane
(Table X), NMOR transferred from the egg white to the membrane. NMOR differed from
NDMA as less NMOR transferred from the egg white to the membrane. NMOR
transferred from the membrane to the yolk during the 24-h incubation period. The results
suggest dynamic movement of NMOR between the membrane and yolk (Table XI).
Transfer to the yolk also was observed in the egg white-yolk matrix (Table XII).
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TABLE X. NMOR transfer from the egg white to the membrane during a 24-h
experiment (1 mg added)
Egg white
Time

Amount

Membrane

Relative

Amount

Percent

a

Total

Relative

Amount

Loss

Percent

(h)

(mg)

(%)

(mg)

(%)

(mg)

(%)

1

0.49 (0.009)a

68

0.23 (0.029)

32

0.72

28

4

0.58 (0.053)

75

0.19 (0.009)

25

0.77

23

6

0.54 (0.009)

64

0.30 (0.001)

36

0.84

16

10

0.61 (0.015)

75

0.20 (0.007)

25

0.81

19

16

0.53 (0.035)

71

0.22 (0.071)

29

0.75

25

24

0.52 (0.139)

71

0.22 (0.001)

30

0.74

26

Values in parenthesis indicate standard deviations (n = 3)

46
TABLE XI. NMOR transfer from the membrane to the yolk during a 24-h
experiment (1 mg added)
Membrane
Time

Amount

Yolk

Relative

Amount

Percent

a

Total
Relative

Amount

Loss

Percent

(h)

(mg)

(%)

(mg)

(%)

(mg)

(%)

1

0.46 (0.017)a

53

0.41 (0.037)

47

0.87

13

4

0.41 (0.006)

49

0.43 (0.091)

51

0.84

16

6

0.29 (0.055)

26

0.82 (0.040)

74

1.11

14

10

0.40 (0.012)

50

0.40 (0.011)

50

0.8

20

16

0.56 (0.135)

65

0.30 (0.021)

35

0.86

14

24

0.37 (0.002)

42

0.52 (0.012)

58

0.89

11

Values in parenthesis indicate standard deviations (n = 3)
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Table XII. NMOR transfer from the egg white to the yolk during a 24-h experiment
(1 mg added)
Egg white
Time

Amount

Relative

Membrane
Amount

Percent

Amount

Percent

Total

Relative

(mg)

(%)

(mg)

(%)

(mg)

(%)

1

0.49

64

0.13

17

0.15

20

4

0.56

(0.012)
78

(0.013)
6

0.53

0.58

62

0.57
(0.003)

10

0.12

74

0.08

14

10

0.10
(0.041)

0.21

(mg)

(%)

0.77

23

0.72

28

0.86

14

0.78

22

0.75

25

24

0.12

15

(0.010)
13

Loss

13

(0.006)

(0.004)
76

0.09
(0.009)

(0.151)

(0.009)
24

(0.002)

( 0.015)

(0.012)
10

0.07

Amount

Percent

(h)

(0.001)a

a

Relative

Yolk

0.08
(0.070)

Values in parenthesis indicate standard deviations (n = 3)

11
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Stability of NNAT
To determine the stability of NNAT in the various fractions of the egg, a known amount
was added to each fraction and the amount remaining was determined with time. The
amounts of NNAT in the egg white and yolk decreased slightly during the first 10 h, but
then remained relatively constant for at least 24 h (Fig. 6).

Fig. 6. NNAT in albumin (egg white) (●) and yolk (○) in a 24-h experiment. Error bars
indicate mean standard deviations; where absent bars fall within symbols.

NNAT Transfer among Egg Fractions
In the egg white and membrane, the amount of NNAT reached a maximum at 4 h
and then progressively decreased (Fig. 7). The amount of NNAT decreased in the yolk
after 1 h. After 24 h no NNAT was detected in any fraction. The lack of change in
atrazine concentrations (atrazine was an impurity in NNAT) indicated that NNAT was
not decomposing to atrazine.
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Fig. 7. NNAT concentrations (µg/g) in the albumin (egg white), membrane and yolk, and
total NNAT (mg) in the albumin (egg white) (●), membrane (○) and yolk (▼) during 120
h of incubation. Error bars indicate mean standard deviations; where absent bars fall
within symbols.

The total amount of NNAT in the egg decreased during the 24 h experiment and
none was detected after 24 h (Table XIII).
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Table XIII. Total NNAT in the egg during a 24-h experiment (1 mg added)

a

Amount of

Amount of NNAT lost/

Time

NNAT in egg

unaccounted for

(h)

(mg)

(mg)

(%)

1

0.08 (0.007)a

0.92

92

4

0.08 (0.009)

0.92

92

6

0.01 (0.003)

0.99

99

10

0.01 (0.001)

0.99

99

16

0.01 (0.001)

0.99

99

24

0.0 0 (0.001)

1.00

100

Values in parenthesis indicate standard deviations (n = 3)

Transfer between Fractions
On analyzing the distribution of NNAT between two layers, the amount of NNAT
in the egg white decreased while the amount in the membrane increased within the first 4
h in the egg white-membrane matrix (Table IV). Within 4 h, the amounts of NNAT in the
egg white and the membrane decreased and neither could be detected after 24 h. This
shows that although NNAT transferred from the egg white into the membrane within the
first few hours, NNAT degraded on longer incubation. In the membrane-yolk matrix, the
amount of NNAT in the membrane fraction decreased with time while that in the yolk
remained relatively constant after an initial increase (Table XV), suggesting transfer from
the membrane to the yolk. The distribution of NNAT between the egg white and yolk
also indicated increased transfer from the egg white into the yolk with time (Table XVI).
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TABLE XIV. NNAT transfer from the egg white to the membrane in a 24-h
experiment (1 mg added)
Egg white
Time

Amount

Membrane

Relative

Amount

Percent

a

Total

Relative

Amount

Loss

Percent

(h)

(mg)

(%)

(mg)

(%)

(mg)

(%)

1

0.31 (0.003)a

84

0.06 (0.010)

16

0.37

63

4

0.23 (0.075)

70

0.1 (0.011)

30

0.33

67

10

0.02 (0.030)

50

0.02 (0.050)

50

0.04

96

16

0.01 (0.001)

-

Not detected

-

-

99

24

Not detected

-

Not detected

-

-

100

Values in parenthesis indicate standard deviations (n = 3)
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Table XV. NNAT transfer from the membrane to the yolk during a 24-h
experiment (1 mg added)
Membrane
Time

Amount

Yolk

Relative

Amount

Percent

a

Total
Relative

Amount

Loss

Percent

(h)

(mg)

(%)

(mg)

(%)

(mg)

(%)

1

0.26 (0.002)a

87

0.04 (0.004)

13

0.30

70

4

0.13 (0.007)

48

0.14 (0.006)

52

0.27

73

10

0.07 (0.070)

39

0.11 (0.051)

61

0.18

82

16

0.13 (0.018)

42

0.18 (0.005)

58

0.31

69

24

0.05 (0.011)

39

0.08 (0.008)

61

0.13

87

Values in parenthesis indicate standard deviations (n = 3)
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Table XVI. NNAT transfer from the egg white to the yolk during a 24-h experiment
(1 mg added)
Egg white
Time

Amount

Membrane

Relative

Amount

Percent

Amount

Percent

Total

Relative

(mg)

(%)

(mg)

(%)

(mg)

(%)

1

0.06

60

0.01

10

0.03

30

4

0.03

(0.001)
50

(0.001)
10

0.02

24

0.02

40

0.01

17

40

0.01
(0.006)

Not

0.01
-

(0.016)

0.02

20

0.02

0.02

(%)

0.1

90

0.06

94

0.05

95

0.05

95

0.03

97

40

(0.021)
33

(mg)

40

(0.004)
20

Loss

33

(0.027)

(0.053)

(0.070)

detected

(0.010)

(0.070)

(0.012)
16

0.01

Amount

Percent

(h)

(0.003)a

a

Relative

Yolk

0.02
(0.001)

67

Values in parenthesis indicate standard deviations (n = 3)

The distribution of the nitrosamines in unfertilized chicken eggs indicates that while most
of the NDMA and NMOR remained in the egg white, NNAT rapidly moved into the
yolk. The total amount of NNAT decreased with time (Fig. 8).
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Fig. 8. Distribution of NDMA, NMOR and NNAT in the albumin (egg white) (♦),
membrane (■) and yolk (▲) during a 24-h incubation.

A comparison among the three compounds shows that NDMA and NMOR are
similar in their transfer behavior in that both have a greater affinity for the yolk fraction
over the egg white fraction (Table XVII). Although the concentration of NNAT is very
low compared to NDMA and NMOR, it readily moves into the yolk. The larger Yolk/Egg
white distribution coefficient for NNAT indicates that it has a greater affinity for yolk
(larger bioconcentration potential) than NDMA or NMOR.
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Table XVII. Maximum nitrosamine concentrations in the egg fractions
Highest concentration

NDMA

NMOR

NNAT

Egg white (µmol/g)

0.24 (0.02)a

0.4 (0.02)

0.03 (0.02)

Membrane (µmol/g)

0.22 (0.15)

0.24 (0.02)

0.002 (0.02)

Yolk (µmol/g)

0.26 (0.005)

0.46 (0.02)

0.11(0.02)

1.08

1.15

3.67

Yolk/Egg white
(Distribution coefficient)
a

Values in parenthesis indicate standard deviations (n = 3)

The biological effects of nitrosamines depend in part on their stability and transfer
behavior. The studies with unfertilized chicken eggs indicate that NDMA, NMOR and
NNAT partition from the egg white into the yolk because temporal decreases in their
amounts in the egg white and membrane were accompanied by concomitant increases in
the yolk. All three compounds were also fairly stable in the yolk fraction. NNAT has a
higher affinity than NDMA and NMOR for the more lipophilic yolk fraction, consistent
with its octanol-water partition coefficient (Kow). This suggests that it may have a greater
potential to bioconcentrate than NDMA and NMOR.
A loss in the total amount of the nitrosamines with time suggests that they may be
decomposing or denitrosating. Haussmann and Werringloer (1987) and Appel et al.
(1991) demonstrated two possible pathways by which nitrosamines denitrosate in
biological media: one electron reduction that produces NO and the secondary amine or
one electron abstraction that liberates NO via an oxidative mechanism involving the
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formation of a primary amine and the corresponding aldehyde. Because the parent
compounds of the nitrosamines were not detected in this study, decomposition or
denitrosation in the yolk likely occurred via an oxidative mechanism (i.e. one electron
abstraction). This mechanism also liberates NO, which may subsequently affect
development of chicken embryos.

Teratogenic Potential of Selected Nitrosamines
From the studies with unfertilized eggs, it was determined that all three nitrosamines
partition into the yolk where they are all fairly stable. Decreases in the total amounts of
nitrosamines may be due to denitrosation or decomposition. It was hypothesized that the
presence of the nitrosamine may alter NO levels and affect development. Thus, studies
were conducted with fertilized chicken eggs to determine the impact of the three
nitrosamines on the development of chicken embryos. The embryos were harvested at
days 3 and 5 and examined microscopically for any soft tissue or skeletal abnormalities.
All three nitrosamines adversely affected development of the chicken embryos to
varying degrees. Malformations were observed in embryos exposed to much lower
concentrations of NNAT than NDMA or NMOR.

Impact of NDMA on developing embryos
Fertilized chicken eggs were treated with 12.5, 25.0, or 50.0 µg NDMA in 50 µL of DD
water. Mortality and deformities were observed only in embryos treated with 25 µg and
higher doses of NDMA (Fig 9).
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Number Affected (%)

60
50
40
30
20
10
0
0

12.5

25

50

Dose (µg)

Fig. 9. Impact of NDMA dose (in 50 µL DD water) on chicken embryo mortality (

)

and malformations ( )

The most common defects observed on exposure to NDMA included gastroschisis
(33%), heart defects, neural tube defects (22% each), microphthalmia (11%) and caudal
regression (11%).
Analysis of the frequency of mortality or abnormalities resulting from NDMA
exposure using chi square test (SAS, Cary, NC) indicated that NDMA does not
significantly affect development in chicken embryos (p > 0.05). There was also no
difference within treatments; i.e., between dosage groups of NDMA (p > 0.05) and thus
there was no dose – response relationship. No significant association was observed
between exposure to NDMA and embryo mortality observed in the embryos (p > 0.05).
Analysis of the relative risk of mortality or abnormalities from exposure to NDMA is
very low (RR < 1.0, 95% CI).
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Impact of NMOR on developing embryos
Fertilized chicken eggs were treated with 25, 250, 1250, 2500, 5000, and 7500 µg NMOR
in 50µL DD water. Mortality and abnormalities were observed in embryos treated with
high doses of NMOR (≥2500 µg) (Fig 10).

Number Affected (%)

70
60
50
40
30
20
10
0
0

25

250

1250
2500
Dose (µg)

5000

7500

Fig. 10. Impact of NMOR dose (in 50 µL DD water) on chicken embryo mortality ( )
and malformations ( )

Gastroschisis was the most frequently occurring malformation (30%), followed by
heart defects (~ 26%). Other defects observed include neural tube defects,
microphthalmia and caudal regression (11, 11, and 22%, respectively).
A chi square test was used to assess relationships between exposure to varying
doses of NMOR and the effects observed (mortality and malformations). On comparing
overall exposure to NMOR and subsequent effects (mortality and deformity), NMOR had
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a significant adverse effect on the developing embryos (p < 0.05). There also was a
difference between doses of NMOR (p < 0.05) with respect to the effect they produce.
NMOR exposure (combining all doses) was associated with embryo death (p <
0.05). There also was a significant dose – response relationship; larger doses of NMOR
induced a high level of mortality in exposed chicken embryos. An analysis of relative risk
indicated a greater risk of mortality in embryos treated with NMOR than in the controls
(RR < 1.0, 95% CI).
NMOR exposure (combining all doses) was associated with malformations (p <
0.05). However, there were no significant differences among the NMOR doses. Relative
risk analysis indicated that the chance of the embryos being malformed is greater for
embryos treated with NMOR than for controls (95% CI). A comparison (by chi square
test) of each NMOR dose with the control shows that there is a significant association
between exposure and malformations and mortality at doses ≥2500 µg.

Impact of NNAT on developing embryos
Fertilized chicken eggs were treated with 0.06, 0.01, 0.23, 0.46, 0.91, 1.82, 3.63, 5.50,
7.25, and 14.50 µg NNAT in 50µL DD water. Adverse effects (mortality and
malformations) were observed in embryos exposed to doses as low as 0.06 µg NNAT
(Fig 11). NNAT exposure resulted in malformations at lower doses than NDMA or
NMOR, therefore of the three nitrosamines, NNAT was the most potent embryotoxic
compound.
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Fig. 11. Impact of NNAT dose (in 50 µL DD water) on mortality ( ) and malformations
( )

Heart defects (ectopic and abnormally looped heart) and gastroschisis (each 24%)
were the most frequently observed defects observed following exposure to NNAT. Other
defects include caudal regression (19%), craniofacial hypoplasia, microphthalmia (each
11%) and neural tube defects (8%). Some of the embryos (4%) showed anophthalmia,
which was not observed in embryos exposed to either NDMA and NMOR. Some of the
defects are shown in Fig 12.
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NNAT 3.63 µg/50 µL

Normal 5 day old embryo
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4
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5

6

NNAT 1.82 µg/50 µL

NNAT 0.91 µg/50 µL
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1
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2
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4

5
5
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NNAT 0.46 µg/50 µL

NNAT 0.06 µg/50 µL

Fig. 12. Malformations in 5-day-old chicken embryos following exposure to NNAT. 1=
neural tube defect, 2=craniofacial hypoplasia, 3=microphthalmia, 4=ectopic heart, 5=
gastroschisis, 6=caudal regression

A chi square test was used to evaluate the impact of NNAT on mortality and
malformations in chicken embryos. Exposure to NNAT adversely affected (mortality and
malformation) chicken embryos (p < 0.05), although there is no clear dose-response
relationship between various doses of NNAT and either lethality or observed
abnormalities.
The relationship between mortality and NNAT exposure was evaluated using a chi
square test and relative risk analysis. There was an association between NNAT exposure
(all doses) and embryo mortality (p < 0.05) but there was no difference among the doses.
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Relative risk analysis showed a greater chance of mortality in chicken embryos exposed
to NNAT (the chance of control embryos remaining alive was 1.1 times greater than
those exposed to NNAT (95% CI)).
Analysis of the impact of NNAT (all doses) on malformations showed a significant
association (p < 0.05) between exposure to NNAT and subsequent deformity. However,
there was no significant association between NNAT dose and defect. Assessment of
relative risk indicates that the chance of an embryo developing normally is 1.3 times
greater for controls than for those treated with NNAT (95% CI); i.e. the risk of
malformations from exposure to NNAT is greater than if there is no exposure. A
comparison (chi square test) of each NNAT dose with the control showed a significant
association between exposure and defect at 0.46, 0.91, 3.63, 5.50, and 7.25 µg in 50 µL
DD water.
There is conflicting evidence about the adverse effects of atrazine. Atrazine may
be an endocrine disrupter in some animal models (mainly amphibian) (Gammon et al.
2005). Atrazine has been shown to affect development in rats and rabbits (delayed
skeletal ossification) and the reproductive NOEL is 25 mg/kg body weight/d (Gammon et
al. 2005). The present studies with chicken embryos showed that 16.5 µg atrazine was
neither teratogenic nor lethal to chicken embryos.
Teratogenic potential and lethality varied among the three nitrosamines tested.
NDMA, a known hepatotoxin and carcinogen, was neither lethal nor teratogenic in
chicken embryos at the doses administered. Previous work with chicken embryos showed
that NDMA is lethal or inhibits growth (Maduagwu and Bassir 1979). Inoculating White
Leghorn chicken eggs with 2.25 mg/mL NDMA (similar to the methodology of the
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present studies) on the tenth day of development resulted in 100% mortality. However,
these effects were not observed in the present study. NMOR was teratogenic and lethal at
relatively high doses (≥2500 µg). NNAT proved to be the most potent teratogen (lowest
dose at which malformations were observed was 0.455 µg). There was no clear doseresponse relationship with NNAT because it was teratogenic at 0.91 µg but not at the
higher dose of 1.82 µg. It also induced defects at doses of 3.63 µg to 7.25 µg but not at
the largest dose of 14.50 µg.
Despite the lack of a clear dose-response relationship between NNAT and the
observed teratogenic effects, this study shows that exposure to NNAT or the endogenous
formation of NNAT could be potentially harmful. Research is limited regarding exposure
to atrazine and NNAT and the potential for in vivo formation of NNAT from exposure to
atrazine and nitrate. Atrazine, due to its weak basicity, nitrosates rapidly (200 times faster
than dimethylamine at pH 2 (Mirvish et al. 1991) and thus exposure to atrazine poses a
risk for endogenous formation of NNAT. High concentrations of atrazine (1500 µg/kg)
have been detected in well water in Wisconsin, where some wells also have high nitrate
levels (Meisner et al. 1993). This creates the potential for NNAT formation after
ingestion. As observed in experiments with unfertilized eggs, NNAT has a high affinity
for the lipophilic yolk fraction and rapidly moves into the yolk in a short period of time.
NNAT showed a greater bioconcentration potential than NDMA and NMOR, which may
be contributing to the occurrence of the biological effects observed in the experiments
with fertilized eggs.
Several factors may explain the variability in observed effects of the nitrosamines
on the chicken embryos, despite measures taken to control treatment conditions. Embryo
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maturity at the time of treatment/exposure will vary due to small differences in
temperature. There is variability in embryo robustness and genetic susceptibility to a
particular compound or to certain developmental defects. Variability may result from the
combined effects of multiple factors. These factors cannot be excluded with certainty as
contributors to the variability in observed defects. Despite these drawbacks, the chicken
embryo is a useful model for preliminary screening of compounds for teratogenicity. For
a clearer, in-depth understanding of potential teratogenic effects of these and other
environmentally relevant nitrosamines, further study with murine models are warranted
as are epidemiological studies to evaluate associations between nitrosamine exposure and
birth defects.

Impact of NNAT on nitrotyrosine concentrations in chicken embryos
Teratology studies with chicken embryos showed a significant association between
exposure to NNAT and developmental abnormalities. Because transfer studies show
NNAT bioconcentration in yolk and suggest loss with time may be due to denitrosation
or nitrosamine decomposition, it was hypothesized that the defects observed in chicken
embryos may be due to alterations in NO concentrations. As previously mentioned,
measurement of the stable 3-nitrotyrosine is a useful way to provide evidence of NOdependent damage and may reflect one pathway by which NNAT exerts teratogenic
effects. Nitrotyrosine was measured in tissue sonicates from five-day-old chicken
embryos treated with DD water (controls), embryos exposed to NNAT that appeared
normal, and embryos exposed to NNAT that were malformed.
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Malformed five-day-old embryos had higher concentrations of nitrotyrosine than
normal-appearing embryos of the same treatment group (Fig. 13). Paired t-tests were used
to compare nitrotyrosine values in normal and malformed embryos for each treatment.
Malformed embryos treated with 0.06, 0.46, 0.91 and 3.63 µg NNAT had significantly
higher concentrations of nitrotyrosine than treated embryos that appeared normal.
3.5
Normal
Malformed

Nitrotyrosine nM/ug Protein
(normalized to control)

3

2.5

2

1.5

1

0.5

0
Control

0.06

0.23
0.46
NNAT Dose (µg)

0.91

3.63

Fig. 13. Nitrotyrosine concentrations in malformed 5-day-old embryos exposed to NNAT

One-way analysis of variance (ANOVA) showed that nitrotyrosine concentrations
in normal-appearing embryos treated with 0.06, 0.46 and 3.63 µg NNAT were
significantly smaller than those in controls (p < 0.05). Nitrotyrosine concentrations were
greater (p < 0.05) in malformed embryos treated with 0.46 and 0.91 µg NNAT than in the
controls. What comprises “normal” nitrotyrosine concentrations in developing chicken
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embryos is uncertain. In our study we observed high levels of nitrotyrosine in the controls
which could indicate stress induced by rapid mitotic divisions and subsequent cellular
differentiation during embryogenesis and organogenesis. At higher doses of NNAT
exposure, where nitrotyrosine concentrations were observed to be lower than controls,
other mechanisms of denitrosation/dealkylation may be influencing NO and subsequently
nitrotyrosine levels.
One-way ANOVA analysis also was used to compare nitrotyrosine concentrations
in embryos (normal and malformed combined) receiving different doses of NNAT.
Nitrotyrosine was greater (p < 0.05) in embryos treated with 0.91 µg NNAT than in
embryos treated with 0.06 µg NNAT. Embryos treated with 0.23, 0.46 and 0.91 µg
NNAT had significantly larger concentrations of nitrotyrosine than those treated with the
largest dose of NNAT (3.63 µg). The large 3.63 µg dose may have induced a different
deleterious response, resulting in overall lower nitrostyrosine concentrations.
The ANOVA showed that nitrotyrosine levels were significantly larger in treated
malformed embryos than in treated, normal-appearing embryos. These experiments show
that exposure to NNAT can affect nitrotyrosine concentrations in five-day-old chicken
embryos. NO-mediated stress may reflect one pathway by which NNAT exerts
teratogenic effects.
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CONCLUSIONS AND RECOMMENDATIONS
The main objectives of this study were to use unfertilized chicken eggs and developing
chicken embryos to evaluate the stability, biological transfer and potential teratogenicity
of three environmentally relevant nitrosamines: NDMA, NMOR and NNAT.
Experiments using unfertilized chicken eggs showed that all three nitrosamines transfer
from the egg white into the yolk where they are relatively stable. NNAT has a greater
potential to bioconcentrate than NDMA and NMOR due to its higher affinity for the yolk
fraction of the egg. A decrease in the total amounts of the three nitrosamines in the egg
yolk suggests that they may be denitrosating (or otherwise decomposing) and releasing
NO. Alterations in NO levels can affect intracellular signaling and adversely impact
embryonic and fetal development. Studies with fertilized chicken eggs showed the three
nitrosamines were detrimental to the development of chicken embryos to varying
degrees. Observed abnormalities include neural tube defects, craniofacial hypoplasia,
microphthalmia, anophthalmia, heart defects, gastroschisis, and caudal regression.
Malformations were observed in embryos exposed to much lower concentrations of
NNAT than NDMA or NMOR proving that NNAT was the most potent teratogen.
Exposure to NNAT was associated with developmental abnormalities in chicken
embryos. However, atrazine, the parent compound of NNAT, did not affect development.
It was hypothesized that defects observed in chicken embryos may be due to alterations
in NO concentrations resulting from exposure to NNAT. Subsequent test showed
significantly higher levels of nitrotrotyrosine, a stable marker of NO and subsequent
nitrosative stress, in NNAT-treated, five-day-old embryos with malformations than in
treated, normal-appearing embryos.
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Considering the increasing prevalence of nitrates in ground and drinking water and
the widespread use of atrazine, data are inadequate about potential exposure to NNAT.
Epidemiological studies concerning potential exposure to NNAT and other nitrosamines
are needed. Laboratory studies also need to be conducted to quantify the exposure and
kinetics of a given dose of the nitrosamine absorbed by chicken/rodent embryos, which
can then be used to estimate exposure levels in humans. Although much is known about
the carcinogenic effects of nitrosamines, there is limited research regarding their
teratogenic impacts and the mechanisms by which they induce abnormal development.
More epidemiological studies are needed to assess the association between exposure to
these and other nitrosamines and adverse fetal outcomes.
NNAT may be teratogenic and nitrotyrosine, a marker of NO-dependent oxidative
stress, may reflect one pathway through which nitrosamines could exert their teratogenic
effects. Further studies are needed to understand this and other possible mechanisms. The
activation of guanylyl cyclase by low concentrations of NO is the major pathway of NO
signaling that is involved in the regulation of many physiological functions. An increase
or decrease in the NO levels due to nitrosamine exposure could disrupt the normal
activation of guanylyl cyclase. Levels of NO and guanylyl cyclase could be determined
after nitrosamine exposure to evaluate this possible mechanism.
Apoptosis is crucial during development (sculpting digits and extremities and
governing the connection between central nervous system, distal structures and cardiac
development). Therefore another focus for future investigations would be to extend areas
of apoptosis leading to malformations. Depending on which organ is malformed,
embryos (chicken or rodent) can be evaluated for disruption of apoptosis in the
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primordial tissues that develop into the affected tissue. Cellular injury resulting from
reactive nitrogen species is another parameter that can be studied.
The unfertilized chicken egg model provides a useful model to study the biological
stability and transfer of chemical compounds. While the chicken embryo is a faster and
relatively inexpensive model to screen compounds for potential teratogenicity, further
studies with murine models are required to reach firm conclusions regarding the
teratogenic behavior of nitrosamines.
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APPENDIX A: STABILITY AND TRANSFER OF SELECTED NITROSAMINES
Average weight of egg fractions
Egg Fraction

Average weight
(g)

Egg white

30.0

Membrane

8.0

Yolk

12.0

Whole egg

50.0

(without shell)

Percent recovery of nitrosamines from each fraction of egg
Egg Fraction

NDMA

NMOR

NNAT

(%)

(%)

(%)

Egg White

100

100

49

Membrane

80

88

63

Yolk

60

99

37
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APPENDIX B: TERATOGENIC POTENTIAL OF SELECTED NITROSAMINES
NDMA
Number of eggs treated with NDMA
Dose (µg)

No. treated

No. unfertilized

No. dead

No. malformed

Controls

25

0

1

1

12.5

10

2

0

0

25.0

10

1

0

1

50.0

20

1

2

5
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SAS output
Case-Control Study of Malformation
The FREQ Procedure

Statistics for Table of Treatment by Outcome
Statistic
Chi-Square

DF

Value

Prob

6

6.6753

0.3519

Chi square test shows that no statistically significant relationship exists between
treatment with NDMA and subsequent adverse effects (i.e. mortality and deformity)
in chicken embryos.
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Case-Control Study of Malformation

The FREQ Procedure

Statistics for Table of trt by Outcome

Estimates of the Relative Risk (Row1/Row2)

Type of Study

Value

95% Confidence Limits

Case-Control (Odds Ratio) 0.2576

0.0290

2.2874

Cohort (Col1 Risk)

0.2899

0.0372

2.2604

Cohort (Col2 Risk)

1.1253

0.9622

1.3162 (>1)

Analysis of relative risk indicates that the risk of mortality or malformations in
chicken embryos from exposure to NDMA is very low (95% CI)
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NMOR
Number of eggs treated with NMOR
Dose
(µg)

No.

No.

No.

No.

treated unfertilized dead malformed

Controls

35

3

1

1

25.0

15

2

0

3

250.0

15

2

1

0

1250.0

10

1

0

1

2500.0

30

4

10

8

5000.0

15

0

5

4

7500.0

15

1

11

2
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SAS output
Case-Control Study of Malformation
The FREQ Procedure
Table of Treatment by Outcome
Treatment

Outcome

Statistics for Table of Treatment by Outcome
Statistic
Chi-Square

DF
12

Value
54.5979

Prob
<.0001

Chi square test shows that NMOR has a statistically significant impact on
development of chicken embryos (malformations and death).
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Statistics for Table of Treatment by Outcome
Statistic
Chi-Square

DF
Value
Prob
6 15.0753 0.0197

Chi square test shows that there is a statistically significant relationship between
exposure to NMOR and subsequent malformations in chicken embryos.
Case-Control Study of Malformation
The FREQ Procedure
Statistics for Table of trt by Outcome
Estimates of the Relative Risk (Row1/Row2)
Type of Study
Case-Control (Odds Ratio)
Cohort (Col1 Risk)
Cohort (Col2 Risk)

Value
0.1129
0.1406
1.2455

95% Confidence Limits
0.0144
0.8850
0.0196
1.0100
1.0915
1.4213

Analysis of relative risk indicates that risk of malformations in chicken embryos
from exposure to NMOR is significantly high.
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Statistics for Table of Treatment by Outcome
Statistic
Chi-Square

DF
Value
Prob
6 44.3219 <.0001

Results from chi square test show that there is a statistically significant relationship
between exposure to NMOR and subsequent mortality in chicken embryos.
Case-Control Study of Malformation
The FREQ Procedure
Statistics for Table of trt by Outcome
Estimates of the Relative Risk (Row1/Row2)
Type of Study
Case-Control (Odds Ratio)
Cohort (Col1 Risk)
Cohort (Col2 Risk)

Value
0.0753
0.1042
1.3839

95% Confidence Limits
0.0098
0.5799
0.0148
0.7356
1.1925
1.6061

Analysis of relative risk indicates that risk of death in chicken embryos from
exposure to NMOR is significantly high.
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NNAT
Number of eggs treated with NNAT
Dose
(µg)

No.

No.

No.

No.

treated unfertilized dead malformed

Controls

75

2

0

0

0.06

30

4

3

3

0.12

25

2

3

6

0.23

25

0

0

6

0.46

40

2

4

11

0.91

25

2

4

9

1.82

30

3

2

3

3.63

40

0

3

16

5.50

15

0

0

6

7.25

25

2

1

7

14.50

25

2

0

7
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SAS output

Case-Control Study of Malformation
The FREQ Procedure
Statistics for Table of Treatment by Outcome
Statistic
Chi-Square

DF
20

Value
50.2383

Prob
0.0002

Chi square test shows that NNAT has a statistically significant impact on
development of chicken embryos (malformations and death).
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Case-Control Study of Malformation
The FREQ Procedure
Statistics for Table of Treatment by Outcome
Statistic
Chi-Square

DF
10

Value
32.0366

Prob
0.0004

Chi square test shows that there is a statistically significant relationship between
exposure to NNAT and subsequent malformations in chicken embryos.
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Case-Control Study of Malformation
The FREQ Procedure
Statistics for Table of trt by Outcome
Estimates of the Relative Risk (Row1/Row2)
Type of Study
Cohort (Col2 Risk)

Value
1.3109

95% Confidence Limits
1.2323
1.3946

Analysis of relative risk indicates that risk of malformations in chicken embryos
from exposure to NNAT is significantly high.
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Case-Control Study of Malformation
The FREQ Procedure
Statistics for Table of Treatment by Outcome
Statistic
Chi-Square

DF
10

Value
Prob
20.1202 0.0281

Chi square test shows that there is a statistically significant relationship between
exposure to NNAT and subsequent mortality in chicken embryos.
Case-Control Study of Malformation
The FREQ Procedure
Statistics for Table of trt by Outcome
Estimates of the Relative Risk (Row1/Row2)
Type of Study
Cohort (Col2 Risk)

Value
1.0840

95% Confidence Limits
1.0464
1.1231

Analysis of relative risk indicates that risk of death in chicken embryos from
exposure to NNAT is significantly high.
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APPENDIX C: IMPACT OF NNAT ON NITROTYROSINE
CONCENTRATIONS IN CHICKEN EMBRYOS
Nitrotyrosine concentrations in controls and embryos treated with different doses of
NNAT
No.

Treatment

Nitrotyrosine
nmol/µg Protein

1

Control 1

824.0

2

Control 2

787.6

3

Control 3

14292.4

4

Control 4

699.5

5

Control 5

474.9

6

Control 6

450.8

7

Control 7

438.9

8

Control 8

318.7

9

NNAT 0.06 µg Normal (1)

281.0

10

NNAT 0.06 µg Normal (2)

293.2

11

NNAT 0.06 µg Normal (3)

256.9

12

NNAT 0.06 µg Normal (4)

402.7

13

NNAT 0.06 µg Malformed (1)

407.6

14

NNAT 0.06 µg Malformed (2)

384.7

15

NNAT 0.06 µg Malformed (3)

327.8
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16

NNAT 0.06 µg Malformed (4)

410.0

17

NNAT 0.23 µg Normal (1)

501.2

18

NNAT 0.23 µg Normal (2)

959.9

19

NNAT 0.23 µg Normal (3)

568.7

20

NNAT 0.23 µg Normal (4)

548.6

21

NNAT 0.23 µg Malformed (1)

579.5

22

NNAT 0.23 µg Malformed (2)

501.2

23

NNAT 0.23 µg Malformed (3)

617.5

24

NNAT 0.23 µg Malformed (4)

737.8

25

NNAT 0.46 µg Normal (1)

311.8

26

NNAT 0.46 µg Normal (2)

293.1

27

NNAT 0.46 µg Normal (3)

182.1

28

NNAT 0.46 µg Normal (4)

195.7

29

NNAT 0.46 µg Normal (5)

358.2

30

NNAT 0.46 µg Normal (6)

388.7

31

NNAT 0.46 µg Normal (7)

287.3

32

NNAT 0.46 µg Normal (8)

280.1

33

NNAT 0.46 µg Malformed (1)

676.0

34

NNAT 0.46 µg Malformed (2)

1697.0

35

NNAT 0.46 µg Malformed (3)

1099.0

36

NNAT 0.46 µg Malformed (4)

1105.1

37

NNAT 0.46 µg Malformed (5)

380.8

38

NNAT 0.46 µg Malformed (6)

326.5
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39

NNAT 0.46 µg Malformed (7)

372.8

40

NNAT 0.46 µg Malformed (8)

426.4

41

NNAT 0.91 µg Normal (1)

338.9

42

NNAT 0.91 µg Normal (2)

257.9

43

NNAT 0.91 µg Normal (3)

241.4

44

NNAT 0.91 µg Normal (4)

886.7

45

NNAT 0.91 µg Malformed (1)

1146.4

46

NNAT 0.91 µg Malformed (2)

864.7

47

NNAT 0.91 µg Malformed (3)

758.4

48

NNAT 0.91 µg Malformed (4)

861.3

49

NNAT 3.63 µg Normal (1)

223.6

50

NNAT 3.63 µg Normal (2)

227.7

51

NNAT 3.63 µg Normal (3)

550.7

52

NNAT 3.63 µg Normal (4)

193.2

53

NNAT 3.63 µg Malformed (1)

372.9

54

NNAT 3.63 µg Malformed (2)

306.9

55

NNAT 3.63 µg Malformed (3)

257.0

56

NNAT 3.63 µg Malformed (4)

466.7
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SAS output
Paired t-test to compare nitrotyrosine concentrations in NNAT treated malformed
and NNAT treated normal embryos
Dose: 0.06 µg:
The TTEST Procedure
Statistics
Difference

N

Std Err

Normal - Malformed

4

0.0755
T-Tests

Difference

DF t Value

Normal - Malformed

3

-3.14

Pr > |t|
0.0515- Difference is statistically significant

Dose: 0.23 µg:
The TTEST Procedure
Statistics
Difference

N

Std Err

Normal - Malformed

3

0.1

T-Tests
Difference
Normal - Malformed

DF t Value
2

-3.32

Pr > |t|
0.08- Difference is not statistically significant
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Dose: 0.46 µg:
The TTEST Procedure
Statistics
Difference

N

Std Err

Normal - Malformed

8

0.59
T-Tests

Difference

DF t Value

Normal - Malformed

7

-2.54

Pr > |t|
0.0388- Difference is statistically significant

Dose: 0.91 µg:
The TTEST Procedure
Statistics
Difference

N

Std Err

Normal - Malformed

3

0.27
T-Tests

Difference

DF t Value

Normal - Malformed

2

-7.49

Pr > |t|
0.0173- Difference is statistically significant

Dose: 3.63 µg:
The TTEST Procedure
Statistics
Difference

N

Std Err

Normal - Malformed

4

0.11
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T-Tests
Difference

DF t Value

Normal - Malformed

3

-5.49

Pr > |t|
0.0119- Difference is statistically significant

One way analysis of variance (ANOVA) to compare nitrotyrosine concentrations in
NNAT treated and control embryos
The SAS System
The Mixed Procedure

Number of Observations Read

55

Number of Observations Used

55

Number of Observations Not Used

0

Differences of Least Squares Means
Effect

Treatment

Treatment

Adj P

Treatment NNAT 0.06 Normal

Control

0.4877

Treatment NNAT 0.06 Malformed

Control

0.8318

Treatment NNAT 0.23 Malformed

Control

1.0000

Treatment NNAT 0.23 Normal

Control

1.0000

Treatment NNAT 0.46 Malformed

Control

0.6430

Treatment NNAT 0.46 Normal

Control

0.1917

Treatment NNAT 0.91 Malformed

Control

0.2082

Treatment NNAT 0.91 Normal

Control

0.9655

Treatment NNAT 3.63 Malformed

Control

0.6921
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Treatment NNAT 3.63 Normal

Control

0.2468

The adjusted P values indicate that nitrotyrosine concentrations were not
statistically significantly different between NNAT treated (malformed and normal)
five day old embryos and the controls.

One way analysis of variance (ANOVA) to compare nitrotyrosine concentrations in
embryos treated with various doses of NNAT
The Mixed Procedure
Differences of Least Squares Means
Effect

Trt

Trt

Pr > |t

Trt

NNAT 0.06

NNAT 0.23

0.0829

Trt

NNAT 0.06

NNAT 0.46

0.1034

Trt

NNAT 0.06

NNAT 0.91

0.0125

Trt

NNAT 0.06

NNAT 3.63

0.6283

Trt

NNAT 0.23

NNAT 0.46

0.6562

Trt

NNAT 0.23

NNAT 0.91

0.4628

Trt

NNAT 0.23

NNAT 3.63

0.0351

Trt

NNAT 0.46

NNAT 0.91

0.1807

Trt

NNAT 0.46

NNAT 3.63

0.0390

Trt

NNAT 0.91

NNAT 3.63

0.0047
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The p-values indicate that there was a significant difference in the nitrotyrosine
concentrations of embryos treated with 0.06 µg NNAT and those treated with NNAT
dose 0.91 µg. Similarly, there was a significant difference in the nitrotyrosine
concentrations of embryos treated with 0.23 µg NNAT and those treated with the
highest NNAT dose of 3.63 µg. There was also a significant difference in the
nitrotyrosine concentrations of embryos treated with 0.46 µg and 0.91 µg NNAT and
those treated with 3.63 µg NNAT.
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One way analysis of variance (ANOVA) to compare nitrotyrosine concentrations in
controls with embryos exposed to NNAT that were normal
The SAS System
The Mixed Procedure
Differences of Least Squares Means

Effect

Trt

Trt

Adj P

Trt

NNAT 0.06

Control

0.0586

Trt

NNAT 0.23

Control

0.9989

Trt

NNAT 0.46

Control

0.0089

Trt

NNAT 0.91

Control

0.5314

Trt

NNAT 3.63

Control

0.0145

The p-values indicate that the nitrotyrosine concentrations in normal – appearing
embryos treated with 0.46µg and 3.63 µg NNAT were significantly different from
nitrotyrosine in control embryos.

